Correlation Between Lipocine and ECGI Holdings

Can any of the company-specific risk be diversified away by investing in both Lipocine and ECGI Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and ECGI Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lipocine and ECGI Holdings, you can compare the effects of market volatilities on Lipocine and ECGI Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of ECGI Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and ECGI Holdings.

Diversification Opportunities for Lipocine and ECGI Holdings

0.1

Correlation Coefficient

Lipocine  ECGI Holdings

Average diversification

The 3 months correlation between Lipocine and ECGI is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and ECGI Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ECGI Holdings and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with ECGI Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ECGI Holdings has no effect on the direction of Lipocine i.e., Lipocine and ECGI Holdings go up and down completely randomly.

Pair Corralation between Lipocine and ECGI Holdings

Given the investment horizon of 90 days Lipocine is expected to under-perform the ECGI Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Lipocine is 2.69 times less risky than ECGI Holdings. The stock trades about -0.1 of its potential returns per unit of risk. The ECGI Holdings is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  0.10  in ECGI Holdings on December 19, 2024 and sell it today you would earn a total of  0.00  from holding ECGI Holdings or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lipocine  vs.  ECGI Holdings

Lipocine

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lipocine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

ECGI Holdings

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ECGI Holdings are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting technical and fundamental indicators, ECGI Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lipocine and ECGI Holdings

The main advantage of trading using opposite Lipocine and ECGI Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, ECGI Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ECGI Holdings will offset losses from the drop in ECGI Holdings' long position.

The idea behind Lipocine and ECGI Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.